Skip to main content
See every side of every news story
Published loading...Updated

Wells Fargo & Company Forecasts Strong Price Appreciation for Bristol Myers Squibb (NYSE:BMY) Stock

Summary by marketbeat.com
Wells Fargo & Company raised their price objective on Bristol Myers Squibb from $53.00 to $55.00 and gave the company an "equal weight" rating in a research note on Wednesday.

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

themarketsdaily.com broke the news in on Wednesday, December 10, 2025.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal